Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Lactobacillus intervention on mice with alcoholic liver disease.

PROVIDER: PRJNA1018882 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR26111618_1.fastq.gz	Fastqsanger.gz
	SRR26111618_2.fastq.gz	Fastqsanger.gz
	SRR26111619_1.fastq.gz	Fastqsanger.gz
	SRR26111619_2.fastq.gz	Fastqsanger.gz
	SRR26111620_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 84

Similar Datasets

Transcriptional profiling of mouse liver tissue following control, choline and methonine/choline deficient diet intervention

Project description:Choline and methionine/choline deficient diets are widely used to generate severe rodent hepatic steatosis and steatohepatitis in an attempt to reflect stages of human non-alcoholic fatty liver disease (NAFLD). The underlying mechanism of hepatic injury in these models, and how this reflects human disease remains incompletely understood. We used detailed transcriptional analysis to interrogate the molecular mechanisms of this intervention and its similarity to human disease. Adult C57Bl/6J mice were maintained on control, choline deficient (CDD) or methionine/choline deficient (MCDD) diets for 4 weeks. Isolated liver RNA was used for transcriptional profiling by micro array analysis.

2016-06-01 | E-MTAB-3943 | biostudies-arrayexpress

Transcriptomic profiling of liver tissue from control, DHT-induced PCOS-NAFLD model, and baicalin-treated mice using RNA-seq

Project description:This study aimed to characterize the liver transcriptomic changes in a mouse model of polycystic ovary syndrome (PCOS)–related non-alcoholic fatty liver disease (NAFLD) and to assess the therapeutic effects of baicalin (BA). Female C57BL/6J mice were implanted subcutaneously with dihydrotestosterone (DHT) pellets to induce PCOS-NAFLD. Liver tissues from control, model, and BA-treated mice were collected for RNA sequencing (RNA-seq). Differential gene expression and functional enrichment analyses were performed to identify biological processes and pathways associated with disease progression and BA intervention.

2025-09-24 | GSE305214 | GEO

Project description:Intervention effect of Lactobacillus helveticus LZ-R-5 on alcoholic fatty liver

| PRJNA821384 | ENA

Project description:Dietary Intervention on Alcoholic Liver Fibrosis

| PRJNA597183 | ENA

Project description:Lactobacillus plantarum NA136 improves the non-alcoholic fatty liver disease

| PRJNA604078 | ENA

Small RNA profiling in mouse alcohol-induced liver injury and steatosis model.

Project description:Complement is known to play a role in alcoholic fatty liver disease (AFLD), but the underlying mechanisms are poorly understood, thereby constraining the development of a rational approach for therapeutic intervention in the complement system.here we demonstrate protection in wild type mice by treatment with CR2-Crry, a C3 inhibitor that specifically targets sites of complement activation. We found that the expression of glycine transfer (t) RNA-derived fragments (Gly-tRFs) is upregulated in ethanol-fed mice, and that inhibition of Gly-tRFs in vivo decreases chronic ethanol-feeding-induced hepatosteatosis without affecting inflammation

2019-08-01 | GSE126047 | GEO

Probiotics-Mediated Reduction of Inflammatory Gut-Bacteria Improves MASLD via Fecal Lipidome Remodeling

Project description:This dataset contains raw high-resolution mass spectrometry data from a randomized controlled trial evaluating probiotic supplementation in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) (ClinicalTrials.gov Identifier: NCT04555434). Participants received placebo or probiotic capsules containing Pediococcus pentosaceus, Lactobacillus lactis, or Lactobacillus helveticus for 8 weeks. Fecal samples collected before and after intervention from participants with high medication adherence (at least 98%) were analyzed using untargeted metabolomic and lipidomic profiling. The data capture probiotic-associated alterations in fecal metabolites and lipid species related to gut-liver axis modulation and hepatic function.

2026-02-22 | MSV000100934 | MassIVE

Gene Expression in IGT6

Project description:A comparison of liver gene expression in a novel strain of mice with insulin resistance and fatty liver disease (Non alcoholic steatohepatitis - NASH)

2011-12-31 | E-MTAB-291 | biostudies-arrayexpress

Project description:Lactobacillus helveticus ZJUIDS12 modulates intestinal microorganisms in mice with chronic alcohol-induced alcoholic liver disease

| PRJNA1065509 | ENA

Project description:Gut microbiota of mice with acute alcoholic liver disease

| PRJNA884989 | ENA